Gerresheimer AG (GRRMF)
OTC PINK OTC PINK Primary Summary
GRRMF Chart
Gerresheimer cuts guidance for 2025 citing weak demand
German packaging and medical equipment maker Gerresheimer cut its guidance for 2025 on Monday, citing continued weak demand in the cosmetics sector and a decline in demand for containment solutions for liquid medications.
Gerresheimer: Strong Growth Projections Make Stock Look Cheap
Gerresheimer's strategic shift to value-driven solutions in pharma packaging supports higher margins and justifies a premium valuation over traditional packaging peers. Despite a weak Q1 with net loss and negative cash flow, management guides for strong revenue and margin recovery, projecting 22% EBITDA margin for FY 2025. Long-term outlook is robust: Management expects 8-10% annual revenue growth, EBITDA margin expansion, and double-digit EPS growth as Bormioli integration delivers synergies.
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMF) Q1 2025 Earnings Conference Call April 11, 2025 4:00 AM ET Company Participants Guido Pickert - Vice President, Corporate Investor Relations Dietmar Siemssen - Chief Executive Officer Bernd Metzner - Chief Financial Officer Conference Call Participants James Vane-Tempest - Jefferies Victoria Lambert - Berenberg David Adlington - JPMorgan Odysseas Manesiotis - BNP Paribas Olivier Calvet - UBS Edward Hall - Stifel Delphine Le Louet - Bernstein Alexander Galitsa - HAIB Operator Ladies and gentlemen, welcome to the publication Q1 2025 Results Conference Call. I am George, the Chorus Call operator.
Gerresheimer AG Dividends
| GRRMF In 10 months Estimated | Annual | $1.3 Per Share |
| GRRMF 1 month ago Paid | Annual | $1.3 Per Share |
| GRRMF 1 month ago | Other | $1.43 Per Share |
| GRRMF 7 Jun 2024 Paid | Annual | $1.35 Per Share |
| GRRMF 6 Jun 2024 Paid | Annual | $1.35 Per Share |
| GRRMF 8 Jun 2023 Paid | Annual | $1.25 Per Share |
Gerresheimer AG Earnings
| 10 Oct 2025 (In 2 months) Date | | 0.82 Cons. EPS | - EPS |
| 10 Jul 2025 Date | | 1.05 Cons. EPS | 0.55 EPS |
| 5 Jun 2025 Date | | - Cons. EPS | - EPS |
| 9 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | - Cons. EPS | - EPS |
| GRRMF In 10 months Estimated | Annual | $1.3 Per Share |
| GRRMF 1 month ago Paid | Annual | $1.3 Per Share |
| GRRMF 1 month ago | Other | $1.43 Per Share |
| GRRMF 7 Jun 2024 Paid | Annual | $1.35 Per Share |
| GRRMF 6 Jun 2024 Paid | Annual | $1.35 Per Share |
| GRRMF 8 Jun 2023 Paid | Annual | $1.25 Per Share |
| 10 Oct 2025 (In 2 months) Date | | 0.82 Cons. EPS | - EPS |
| 10 Jul 2025 Date | | 1.05 Cons. EPS | 0.55 EPS |
| 5 Jun 2025 Date | | - Cons. EPS | - EPS |
| 9 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | - Cons. EPS | - EPS |
Gerresheimer AG (GRRMF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Gerresheimer AG ever had a stock split?
Gerresheimer AG Profile
| Medical - Instruments & Supplies Industry | Healthcare Sector | Mr. Dietmar Siemssen CEO | OTC PINK Exchange | DE000A0LD6E6 ISIN |
| DE Country | 13,632 Employees | 9 Jun 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Gerresheimer AG is an established leader in the production and distribution of specialized packaging solutions and drug delivery systems for the pharmaceutical, biotechnology, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. With a rich history dating back to 1864, the company has grown to serve clients globally, with its headquarters situated in Düsseldorf, Germany. It operates through three main divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies, demonstrating a broad and innovative product portfolio designed to meet the complex needs of its clients in Germany and across the world.
Products and Services
- Prefillable Syringes & Packaging Solutions: Gerresheimer AG offers a wide range of prefillable syringes, alongside plastic and glass packaging solutions such as vials, glass cartridges, and ampoules. These crucial components are designed for the safe and effective delivery of medications.
- Bottles & Containers: The company produces both glass and plastic bottles and containers for various applications, along with specialized products like capsules, closures, applicators, and accessories to suit the diverse needs of the industries it serves.
- Drug Delivery Programs: Gerresheimer offers comprehensive services in the development, industrialization, and contract manufacturing of drug delivery programs. Supported by project and quality management services, these solutions cater to inhalers, injection/autoinjectors, pen injectors, and infusion systems, emphasizing the significance of reliable drug delivery mechanisms.
- Diagnostic & Medical Devices: The company manufactures diagnostic and medical devices, including point-of-care tests and laboratory disposables. It also offers chemical and technical bottles, diagnostic polymer vials, dropper bottles, PET bottles, and a variety of medical products such as lancing devices and infusion sets.
- Cosmetic Packaging Solutions: Gerresheimer extends its expertise to the cosmetics industry by providing attractive and functional packaging solutions, including molded glass flacons and jars, tubular glass ampoules, droppers, samplers, vials, and a range of plastic packaging products.
- Pharmaceutical, Laboratory, & Regulatory Affairs Services: The company is not only a manufacturer but also a service provider, offering a spectrum of pharmaceutical, laboratory, and regulatory affairs services to ensure compliance and facilitate the successful launch of products in various markets.
Contact Information
